Business: Local and State

Jan. 15, 2015 @ 06:49 PM

PARK CENTER: RTP forges new direction with The Frontier

A year after purchasing the property, Research Triangle Park opened its first building in the Park Center development Thursday. The space, called The Frontier, is a 142,000 square-foot mix of offices, co-working spaces and free meeting areas.

Jan. 15, 2015 @ 06:19 PM

Morinaga America Foods seeks job candidates for Mebane plant

In anticipation of the opening of its new production facility in Mebane, Morinaga America Foods will hold two information sessions for people interested in careers at the factory. Scheduled to open in March, the company needs production operators, production supervisors and quality technicians. These positions will have pay ranges of $10-$20 per hour.

Jan. 14, 2015 @ 05:09 PM

Duke seeks to stop generic drug incursions

After a federal appeals court ruled in June that its existing patents for an eyelash growth treatment were invalid, Duke University was issued a new patent in December. Now, along with California-based Allergan Inc., the university is using the new patent to fight other companies seeking to make generic versions of the eyelash drug.

Jan. 14, 2015 @ 05:00 PM

Cree sues competitor to protect patents

Cree has filed complaints with the International Trade Commission (ITC) and the U.S. District Court for the Western District against Feit Electric Company and its Taiwan-based supplier, Unity Opto Technology regarding LED lighting products.

Jan. 13, 2015 @ 05:01 PM

Duke University Health System names new CEO

A. Eugene Washington, M.D., an internationally renowned clinical investigator, health-policy scholar and executive at the University of California, Los Angeles (UCLA), will become Duke University’s next chancellor for health affairs and the president and chief executive officer of the Duke University Health System, Duke President Richard H. Brodhead announced Tuesday.

Jan. 11, 2015 @ 06:58 PM

Business Briefs: Global insurer acquires Durham-based firm

News in brief from the local business front.

Jan. 11, 2015 @ 06:23 PM

Career Briefs: Biogen Idec; Health Decisions

Biogen Idec shifts RTP leadership; Health Decisions names new vice president

Jan. 11, 2015 @ 06:01 PM

Buzz: Music store to close in Brightleaf

Offbeat Music will be closing after 11 years in Brightleaf Square.

Jan. 10, 2015 @ 06:00 PM

Southern Season helps fight hunger

Four North Carolina hunger relief organizations are among recipients of grant money from Share the Food Foundation, the nonprofit arm of gourmet grocer Southern Season.

Jan. 09, 2015 @ 01:15 PM

DPS ponders plight of unpaid custodial workers

Durham Public Schools custodians not paid by bankrupt Integrity Custodial Services could know as soon as Monday whether the school district will step up to cover paychecks for two weeks of work they are owed by the now-defunct company.

Jan. 07, 2015 @ 06:20 PM

BCBSNC price tool aims to lower costs

Blue Cross Blue Shield of North Carolina (BCBSNC) has launched an online tool for consumers to compare provider costs for specific procedures in an attempt to lower health care costs.

Jan. 06, 2015 @ 04:27 PM

N.Y. firm buys Roger’s Alley for $6.1 million

Roger’s Alley, the development at 107 E. Parrish St., has sold for nearly $6.1 million.

Dec. 30, 2014 @ 07:24 PM

Wine merchants hope sales sparkle on New Year’s Eve

Some stocked with sparking wines, a number of independent Durham wine shops, beer stores and specialty vendors will be open on New Year’s Eve and ready for business.

Dec. 30, 2014 @ 05:04 PM

Durham-Chapel Hill metro jobless rate drops to 4.8 percent

Unemployment in the Durham-Chapel Hill metropolitan area fell from 5 percent in October to 4.8 percent in November, reaching the lowest rate seen the area since June of 2008.

Dec. 22, 2014 @ 05:58 PM

BioCryst flu treatment receives FDA approval

Joining the list of two other drugs currently approved for flu treatment, BioCryst Pharmaceutical’s influenza treatment RAPIVAB has been approved by the US Food and Drug Administration (FDA).

The drug is the first of its kind as an intravenous single-dose treatment for those who exhibit flu symptoms.